HTA comparators across six EU agencies: what ISPOR 2026 shows
An ISPOR Europe 2026 session compares the comparators and outcomes six European HTA bodies requested for 21 oncology and ATMP drugs. Companion abstracts show why comparator choice drives JCA risk.